[HTML][HTML] Diagnosing lung cancers through examination of micro-RNA biomarkers in blood, plasma, serum and sputum: a review and summary of current literature

J Gyoba, S Shan, W Roa, ELR Bédard - International journal of molecular …, 2016 - mdpi.com
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …

Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature

J Gyoba, S Shan, W Roa, ELR Bédard - 2016 - agris.fao.org
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …

Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature

J Gyoba, S Shan, W Roa… - International Journal of …, 2016 - search.proquest.com
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …

Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature

J Gyoba, S Shan, W Roa… - International journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …

[PDF][PDF] Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of

J Gyoba, S Shan, W Roa, ELR Bédard - Int. J. Mol. Sci, 2016 - researchgate.net
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …

[HTML][HTML] Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature

J Gyoba, S Shan, W Roa… - International Journal of …, 2016 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …

[PDF][PDF] Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of

J Gyoba, S Shan, W Roa, ELR Bédard - Int. J. Mol. Sci, 2016 - pdfs.semanticscholar.org
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …

Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature.

J Gyoba, S Shan, W Roa… - International Journal of …, 2016 - search.ebscohost.com
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …

Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature.

J Gyoba, S Shan, W Roa, EL Bédard - International Journal of …, 2016 - europepmc.org
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …